Roble Belko & Company’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,502
| Closed | – | – | 396 |
|
|
2024
Q1 | $0 | Hold |
4,502
| – | – | ﹤0.01% | 383 |
|
|
2023
Q4 | $0 | Hold |
4,502
| – | – | ﹤0.01% | 365 |
|
|
2023
Q3 | $0 | Hold |
4,502
| – | – | ﹤0.01% | 339 |
|
|
2023
Q2 | $0 | Hold |
4,502
| – | – | ﹤0.01% | 340 |
|
|
2023
Q1 | $1K | Hold |
4,502
| – | – | ﹤0.01% | 288 |
|
|
2022
Q4 | $5K | Hold |
4,502
| – | – | ﹤0.01% | 274 |
|
|
2022
Q3 | $9K | Hold |
4,502
| – | – | ﹤0.01% | 251 |
|
|
2022
Q2 | $7K | Hold |
4,502
| – | – | ﹤0.01% | 256 |
|
|
2022
Q1 | $23K | Hold |
4,502
| – | – | ﹤0.01% | 227 |
|
|
2021
Q4 | $28K | Buy |
+4,502
| New | +$28K | 0.01% | 188 |
|